Display options
Cite
Chen DJ, Li XS, Zhao H, et al. Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study. Oncol Lett. 2016;13(3):1425-1431doi: 10.3892/ol.2016.5530.
Chen, D. J., Li, X. S., Zhao, H., Fu, Y., Kang, H. R., Yao, F. F., Hu, J., Qi, N., Zhang, H. H., Du, N., & Chen, W. R. (2017). Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study. Oncology letters, 13(3), 1425-1431. https://doi.org/10.3892/ol.2016.5530
Chen, Dian-Jun, et al. "Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study." Oncology letters vol. 13,3 (2017): 1425-1431. doi: https://doi.org/10.3892/ol.2016.5530
Chen DJ, Li XS, Zhao H, Fu Y, Kang HR, Yao FF, Hu J, Qi N, Zhang HH, Du N, Chen WR. Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study. Oncol Lett. 2017 Mar;13(3):1425-1431. doi: 10.3892/ol.2016.5530. Epub 2016 Dec 23. PMID: 28454272; PMCID: PMC5403450.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2017 Mar;13(3):1425-1431. doi: 10.3892/ol.2016.5530. Epub 2016 Dec 23.

Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study.

Oncology letters

Dian-Jun Chen, Xiao-Song Li, Hui Zhao, Yan Fu, Huan-Rong Kang, Fang-Fang Yao, Jia Hu, Nan Qi, Huan-Huan Zhang, Nan Du, Wei-R Chen

Affiliations

  1. Department of Oncology, First Affiliated Hospital of The Chinese People's Liberation Army General Hospital, Beijing 100048, P.R. China.
  2. Department of Engineering and Physics, University of Central Oklahoma, Edmond, OK 73034, USA.

PMID: 28454272 PMCID: PMC5403450 DOI: 10.3892/ol.2016.5530

Abstract

The present study aimed to evaluate the efficacy and safety of

Keywords: contact dermatitis; dinitrophenyl; laser; malignant melanoma; metastasis; tumor immunity

References

  1. Curr Opin Immunol. 2004 Apr;16(2):157-62 - PubMed
  2. J Cancer Res Clin Oncol. 2007 Jul;133(7):437-44 - PubMed
  3. J Clin Oncol. 2004 Mar 15;22(6):1118-25 - PubMed
  4. Cancer. 2010 May 1;116(9):2224-33 - PubMed
  5. Lancet Oncol. 2012 Jan;13(1):e32-42 - PubMed
  6. Cancer Immunol Immunother. 2002 Aug;51(6):320-6 - PubMed
  7. Cancer Immunol Immunother. 2002 Oct;51(8):431-9 - PubMed
  8. N Engl J Med. 1972 Feb 24;286(8):399-402 - PubMed
  9. Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):293-5 - PubMed
  10. J Exp Med. 2000 Jul 17;192(2):295-302 - PubMed
  11. Integr Cancer Ther. 2011 Dec;10(4):368-73 - PubMed
  12. Trans Am Ophthalmol Soc. 2009 Dec;107:223-8 - PubMed
  13. Cancer Biol Ther. 2010 Dec 1;10(11):1081-7 - PubMed
  14. Cancer. 1990 Jun 1;65(11):2478-81 - PubMed
  15. J Clin Oncol. 1999 Sep;17(9):2752-61 - PubMed
  16. J Clin Oncol. 1995 Dec;13(12):2895-9 - PubMed
  17. Curr Opin Oncol. 1997 Mar;9(2):205-13 - PubMed
  18. Melanoma Res. 2011 Dec;21(6):524-9 - PubMed
  19. Nat Biotechnol. 2002 Jan;20(1):64-9 - PubMed
  20. Eur J Cancer. 2009 Jan;45(2):228-47 - PubMed
  21. J Am Coll Surg. 1995 Sep;181(3):193-201 - PubMed
  22. Cancer Immunol Immunother. 2011 Jul;60(7):1039-45 - PubMed
  23. Hautarzt. 1998 Jan;49(1):17-22 - PubMed
  24. Clin Exp Dermatol. 2000 Sep;25(6):503-8 - PubMed
  25. Eur J Cancer. 2010 Jan;46(2):270-83 - PubMed
  26. Exp Dermatol. 2010 Aug;19(8):e213-21 - PubMed
  27. Br J Dermatol. 2007 Sep;157(3):531-9 - PubMed
  28. Exp Dermatol. 2009 Apr;18(4):396-403 - PubMed
  29. J Clin Oncol. 2000 Jan;18(1):158-66 - PubMed
  30. Pathol Oncol Res. 2010 Sep;16(3):303-9 - PubMed
  31. Bull Cancer. 2003 Aug-Sep;90(8-9):722-33 - PubMed
  32. Clin Cancer Res. 2003 Feb;9(2):606-12 - PubMed
  33. N Engl J Med. 2012 Mar 8;366(10 ):925-31 - PubMed
  34. Hum Vaccin Immunother. 2012 Aug;8(8):1146-51 - PubMed
  35. Br J Dermatol. 2002 Jul;147(1):62-70 - PubMed
  36. J Clin Oncol. 1998 May;16(5):1752-9 - PubMed
  37. Cancer Res. 2002 Sep 15;62(18):5267-72 - PubMed

Publication Types